IBN Coverage Initiated for Longeveron Inc.
07 sept. 2023 08h30 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Sept. 07, 2023 (GLOBE NEWSWIRE) -- via IBN – Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for...